Structure of the Notch1-negative regulatory region: Implications for normal activation and pathogenic signaling in T-ALL

Blood

Volumn 113, Issue 18, 2009, Pages 4381-4390

  Gordon, Wendy R ^a   Roy, Monideepa ^a   Vardar Ulu, Didem ^b   Garfinkel, Megan ^a   Mansour, Marc R ^c   Aster, Jon C ^a   Blacklow, Stephen C ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b WELLESLEY COLLEGE   (United States)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HETERODIMER; NOTCH1 RECEPTOR; LUCIFERASE; NOTCH1 PROTEIN, HUMAN; NOTCH2 PROTEIN, HUMAN; NOTCH2 RECEPTOR;

ACUTE LYMPHOBLASTIC LEUKEMIA; AMINO ACID SEQUENCE; ARTICLE; GENE; HUMAN; NOTCH1 GENE; NUCLEOTIDE SEQUENCE; POINT MUTATION; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN PROTEIN INTERACTION; SEQUENCE ALIGNMENT; SIGNAL TRANSDUCTION; STEREOSPECIFICITY; T CELL ACUTE LYMPHOBLASTIC LEUKEMIA LYMPHOMA; T CELL LEUKEMIA; CHEMISTRY; GENETICS; METABOLISM; MOLECULAR GENETICS; PATHOLOGY; PROTEIN TERTIARY STRUCTURE; REGULATORY SEQUENCE; SEQUENCE HOMOLOGY; WESTERN BLOTTING; X RAY CRYSTALLOGRAPHY;

AMINO ACID SEQUENCE; BLOTTING, WESTERN; CRYSTALLOGRAPHY, X-RAY; HUMANS; LUCIFERASES; MOLECULAR SEQUENCE DATA; POINT MUTATION; PRECURSOR T-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROTEIN STRUCTURE, TERTIARY; RECEPTOR, NOTCH1; RECEPTOR, NOTCH2; REGULATORY SEQUENCES, NUCLEIC ACID; SEQUENCE HOMOLOGY, AMINO ACID; SIGNAL TRANSDUCTION;

EID: 66149151737     PISSN: 00064971     EISSN: 15280020     Source Type: None    
DOI: 10.1182/blood-2008-08-174748     Document Type: Article

References (50)

1. Bray SJ. Notch signalling: a simple pathway becomes complex. Nat Rev Mol Cell Biol. 2006;7: 678-689.
2. Blaumueller CM, Qi H, Zagouras P, Artavanis- Tsakonas S. Intracellular cleavage of Notch leads to a heterodimeric receptor on the plasma membrane. Cell. 1997;90:281-291. (Pubitemid 27329713)
3. Logeat F, Bessia C, Brou C, et al. The Notch1 receptor is cleaved constitutively by a furin-like convertase. Proc Natl Acad Sci U S A. 1998;95: 8108-8112. (Pubitemid 28326074)
4. Kopan R, Schroeter EH, Weintraub H, Nye JS. Signal transduction by activated mNotch: importance of proteolytic processing and its regulation by the extracellular domain. Proc Natl Acad Sci U S A. 1996;93:1683-1688. (Pubitemid 26075185)
5. Sanchez-Irizarry C, Carpenter AC, Weng AP, Pear WS, Aster JC, Blacklow SC. Notch subunit heterodimerization and prevention of ligand-independent proteolytic activation depend, respectively, on a novel domain and the LNR repeats. Mol Cell Biol. 2004;24:9265-9273. (Pubitemid 39391665)
6. Fehon R, Kooh P, Rebay I, et al. Molecular interactions between the protein products of the neurogenic loci Notch and Delta, two EGF-homologous genes in Drosophila. Cell. 1990;61:523-534. (Pubitemid 20169007)
7. Brou C, Logeat F, Gupta N, et al. A novel proteolytic cleavage involved in Notch signaling: the role of the disintegrin-metalloprotease TACE. Mol Cell. 2000;5:207-216. (Pubitemid 30628080)
8. Mumm JS, Schroeter EH, Saxena MT, et al. A ligand-induced extracellular cleavage regulates gamma-secretase-like proteolytic activation of Notch1. Mol Cell. 2000;5:197-206.
9. De Strooper B, Annaert W, Cupers P, et al. A presenilin- 1-dependent gamma-secretase-like protease mediates release of Notch intracellular domain. Nature. 1999;398:518-522. (Pubitemid 129523590)
10. Selkoe D, Kopan R. Notch and Presenilin: regulated intramembrane proteolysis links development and degeneration. Annu Rev Neurosci. 2003;26:565-597. (Pubitemid 37064944)
11. Struhl G, Greenwald I. Presenilin is required for activity and nuclear access of Notch in Drosophila. Nature. 1999;398:522-525. (Pubitemid 129523591)
12. Struhl G, Greenwald I. Presenilin-mediated transmembrane cleavage is required for Notch signal transduction in Drosophila. Proc Natl Acad Sci U S A. 2001;98:229-234. (Pubitemid 32095892)
13. Yu G, Nishimura M, Arawaka S, et al. Nicastrin modulates presenilin-mediated notch/glp-1 signal transduction and betaAPP processing. Nature. 2000;407:48-54. (Pubitemid 30706870)
14. Nam Y, Sliz P, Song L, Aster JC, Blacklow SC. Structural basis for cooperativity in recruitment of MAML coactivators to Notch transcription complexes. Cell. 2006;124:973-983. (Pubitemid 43344237)
15. Schroeter EH, Kisslinger JA, Kopan R. Notch-1 signalling requires ligand-induced proteolytic release of intracellular domain. Nature. 1998;393: 382-386. (Pubitemid 28269713)
16. Wilson JJ, Kovall RA. Crystal structure of the CSL-Notch-Mastermind ternary complex bound to DNA. Cell. 2006;124:985-996.
17. Ellisen LW, Bird J, West DC, et al. TAN-1, the human homolog of the Drosophila notch gene, is broken by chromosomal translocations in T lymphoblastic neoplasms. Cell. 1991;66:649-661. (Pubitemid 121001701)
18. Weng AP, Ferrando AA, Lee W, et al. Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Science. 2004;306:269-271. (Pubitemid 39336870)
19. Breit S, Stanulla M, Flohr T, et al. Activating NOTCH1 mutations predict favorable early treatment response and long-term outcome in childhood precursor T-cell lymphoblastic leukemia. Blood. 2006;108:1151-1157. (Pubitemid 44232009)
20. De Keersmaecker K, Lahortiga I, Mentens N, et al. In vitro validation of gamma-secretase inhibitors alone or in combination with other anti-cancer drugs for the treatment of T-cell acute lymphoblastic leukemia. Haematologica. 2008;93: 533-542.
21. Mansour MR, Duke V, Foroni L, et al. Notch-1 mutations are secondary events in some patients with T-cell acute lymphoblastic leukemia. Clin Cancer Res. 2007;13:6964-6969. (Pubitemid 350276876)
22. Mansour MR, Linch DC, Foroni L, Goldstone AH, Gale RE. High incidence of Notch-1 mutations in adult patients with T-cell acute lymphoblastic leukemia. Leukemia. 2006;20:537-539. (Pubitemid 43291764)
23. Sulis ML, Williams O, Palomero T, et al. NOTCH1 extracellular juxtamembrane expansion mutations in T-ALL. Blood. 2008;112:733-740.
24. Zhu YM, Zhao WL, Fu JF, et al. NOTCH1 mutations in T-cell acute lymphoblastic leukemia: prognostic significance and implication in multifactorial leukemogenesis. Clin Cancer Res. 2006; 12:3043-3049.
25. Aster JC, Pear WS, Blacklow SC. Notch signaling in leukemia. Annu Rev Pathol. 2008;3:587-613.
26. Chiang MY, Xu ML, Histen G, et al. Identification of a conserved negative regulatory sequence that influences the leukemogenic activity of NOTCH1. Mol Cell Biol. 2006;26:6261-6271. (Pubitemid 44204542)
27. Malecki MJ, Sanchez-Irizarry C, Mitchell JL, et al. Leukemia-associated mutations within the NOTCH1 heterodimerization domain fall into at least two distinct mechanistic classes. Mol Cell Biol. 2006;26:4642-4651. (Pubitemid 43877581)
28. Gordon WR, Vardar-Ulu D, Histen G, Sanchez- Irizarry C, Aster JC, Blacklow SC. Structural basis for autoinhibition of Notch. Nat Struct Mol Biol. 2007;14:295-300.
29. National Center for Biotechnology Information. GenBank. http://www.ncbi.nlm.nih.gov/Genbank. Accessed August 2008.
30. Otwinowsk Z, Minor W. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 1997;276:307-326. (Pubitemid 27085611)
31. McCoy A, Grosse-Kunstleve R, Adams P, Winn M, Storoni L, Read R. Phaser crystallographic software. J Appl Cryst. 2007;40:658-674.
32. Emsley P, Cowtan K. Coot: model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr. 2004;60:2126-2132. (Pubitemid 41742764)
33. Brünger A, Adams P, Clore G. Crystallography and NMR system: a new software suite for macromolecular structure determination. Acta Crystallogr D Biol Crystallogr. 1998;54:905-921. (Pubitemid 28443603)
34. Murshudov G, Vagin A, Dodson E. Refinement of macromolecular structures by the maximum-liklihood method. Acta Crystallogr D. 1997;53:240-245. (Pubitemid 27235885)
35. Holm L, Park J. DaliLite workbench for protein structure comparison. Bioinformatics. 2000;16: 566-567.
36. Krissinel E, Henrick K. Inference of macromolecular assemblies from crystalline state. J Mol Biol. 2007;372:774-797. (Pubitemid 47321791)
37. Miller S, Janin J, Lesk AM, Chothia C. Interior and surface of monomeric proteins. J Mol Biol. 1987; 196:641-656.
38. Aster JC, Xu L, Karnell FG, Patriub V, Pui JC, Pear WS. Essential roles for ankyrin repeat and transactivation domains in induction of T-cell leukemia by notch1. Mol Cell Biol. 2000;20:7505-7515. (Pubitemid 30736875)
39. Research Collaboratory for Structural Bioinformatics. Protein Data Bank. http://www.rcsb.org/pdb.
40. Gordon WR, Arnett KL, Blacklow SC. The molecular logic of Notch signaling: a structural and biochemical perspective. J Cell Sci. 2008;121: 3109-3119.
41. European Bioinformatics Institute. ClustalW. http://www.ebi.ac.uk/Tools/ clustalw2/index.html. Accessed July 2008.
42. Macao B, Johansson DGA, Hansson GC, Hard T. Autoproteolysis coupled to protein folding in the SEA domain of the membrane-bound MUC1 mucin. Nat Struct Mol Biol. 2006;13:71-76. (Pubitemid 43049405)
43. Maeda T, Inoue M, Koshiba S, et al. e. Solution structure of the SEA domain from the murine homologue of ovarian cancer antigen CA125 (MUC16). J Biol Chem. 2004;279:13174-13182. (Pubitemid 38445896)
44. Maris C, Dominguez C, Allain FH. The RNA recognition motif, a plastic RNA-binding platform to regulate post-transcriptional gene expression. FEBS J. 2005;272:2118-2131. (Pubitemid 40655326)
45. Primo ME, Klinke S, Sica MP, et al. Structure of the mature ectodomain of the human receptortype protein-tyrosine phosphatase IA-2. J Biol Chem. 2008;283:4674-4681.
46. Vooijs M, Schroeter EH, Pan Y, Blandford M, Kopan R. Ectodomain shedding and intramembrane cleavage of mammalian Notch proteins is not regulated through oligomerization. J Biol Chem. 2004;279:50864-50873. (Pubitemid 40017825)
47. Nichols JT, Miyamoto A, Olsen SL, D'Souza B, Yao C, Weinmaster G. DSL ligand endocytosis physically dissociates Notch1 heterodimers before activating proteolysis can occur. J Cell Biol. 2007;176:445-458. (Pubitemid 46257272)
48. Parks AL, Klueg KM, Stout JR, Muskavitch MA. Ligand endocytosis drives receptor dissociation and activation in the Notch pathway. Development. 2000;127:1373-1385. (Pubitemid 30232589)
49. Maskos K, Fernandez-Catalan C, Huber R, et al. Crystal structure of the catalytic domain of human tumor necrosis factor-alpha-converting enzyme. Proc Natl Acad Sci U S A. 1998;95:3408-3412. (Pubitemid 28173141)
50. Li K, Li Y, Wu W, et al. Modulation of Notch signaling by antibodies specific for the extracellular negative regulatory region of NOTCH3. J Biol Chem. 2008;283:8046-8054.